Literature DB >> 18663753

Across array comparative genomic hybridization: a strategy to reduce reference channel hybridizations.

Tineke E Buffart1, Daniëlle Israeli, Marianne Tijssen, Sjoerd J Vosse, Alan Mrsić, Gerrit A Meijer, Bauke Ylstra.   

Abstract

Array comparative genomic hybridization (array CGH) is widely used for studying chromosomal copy number aberrations (CNAs) on a genome-wide and high-resolution scale in heritable disorders and cancers. The aim of this study was to test if the separate channels of dual channel arrays can be interchanged (across array) to either make array CGH more sensitive and cost effective and/or to generate profiles of CNAs and copy number variations (CNVs). Therefore the BT474 breast cancer cell line was compared with a mix of normal reference DNAs hybridized on different arrays and days and DNA copy number profiles were evaluated. Quality was assessed, using regular dual channel array CGH as a standard, using four quality measures, i.e., the median absolute deviation value of chromosome 2, the amplitude of the ERBB2 gene amplification, a deletion on chromosome 9, and the deflection on chromosome 8. The quality of the across array CGH profiles matched or even surpassed the quality of regular dual channel array CGH. In addition, this across array approach was tested for genomic DNA derived from formalin-fixed paraffin-embedded tumors tissue samples, resulting in high-quality copy number profiles, comparable to regular dual channel arrays. Finally, we demonstrated this approach to obtain both CNA and CNV profiles. In summary, across array CGH avoids redundant hybridizations of the same reference material in every experiment either allowing hybridization of two test samples on one array or producing both CNA and CNV profiles simultaneously.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18663753     DOI: 10.1002/gcc.20605

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  30 in total

1.  Redefining the MED13L syndrome.

Authors:  Abidemi Adegbola; Luciana Musante; Bert Callewaert; Patricia Maciel; Hao Hu; Bertrand Isidor; Sylvie Picker-Minh; Cedric Le Caignec; Barbara Delle Chiaie; Olivier Vanakker; Björn Menten; Annelies Dheedene; Nele Bockaert; Filip Roelens; Karin Decaestecker; João Silva; Gabriela Soares; Fátima Lopes; Hossein Najmabadi; Kimia Kahrizi; Gerald F Cox; Steven P Angus; John F Staropoli; Ute Fischer; Vanessa Suckow; Oliver Bartsch; Andrew Chess; Hans-Hilger Ropers; Thomas F Wienker; Christoph Hübner; Angela M Kaindl; Vera M Kalscheuer
Journal:  Eur J Hum Genet       Date:  2015-03-11       Impact factor: 4.246

2.  Detection limits of DNA copy number alterations in heterogeneous cell populations.

Authors:  Oscar Krijgsman; Daniëlle Israeli; Hendrik F van Essen; Paul P Eijk; Michel L M Berens; Clemens H M Mellink; Aggie W Nieuwint; Marjan M Weiss; Renske D M Steenbergen; Gerrit A Meijer; Bauke Ylstra
Journal:  Cell Oncol (Dordr)       Date:  2012-11-02       Impact factor: 6.730

3.  EGFR status and KRAS/BRAF mutations in intestinal-type sinonasal adenocarcinomas.

Authors:  Cristina García-Inclán; Fernando López; Jhudit Pérez-Escuredo; Mari Paz Cuesta-Albalad; Blanca Vivanco; Irene Centeno; Milagros Balbín; Carlos Suárez; José Luis Llorente; Mario A Hermsen
Journal:  Cell Oncol (Dordr)       Date:  2012-10-11       Impact factor: 6.730

4.  Establishment and genetic characterization of an immortal tumor cell line derived from intestinal-type sinonasal adenocarcinoma.

Authors:  Jhudit Pérez-Escuredo; Jorge García Martínez; Cristina García-Inclán; Blanca Vivanco; María Costales; César Álvarez Marcos; José Luis Llorente; Mario A Hermsen
Journal:  Cell Oncol (Dordr)       Date:  2011-01-18       Impact factor: 6.730

Review 5.  Experimental designs for array comparative genomic hybridization technology.

Authors:  S K McDonnell; S M Riska; E W Klee; E C Thorland; N E Kay; S N Thibodeau; A S Parker; J E Eckel-Passow
Journal:  Cytogenet Genome Res       Date:  2013-03-27       Impact factor: 1.636

6.  Investigation of a patient with a partial trisomy 16q including the fat mass and obesity associated gene (FTO): fine mapping and FTO gene expression study.

Authors:  Linda van den Berg; Henriette Delemarre-van de Waal; Joan C Han; Bauke Ylstra; Paul Eijk; Maria Nesterova; Peter Heutink; Constantine A Stratakis
Journal:  Am J Med Genet A       Date:  2010-03       Impact factor: 2.802

7.  NMD inhibition fails to identify tumour suppressor genes in microsatellite stable gastric cancer cell lines.

Authors:  Tineke E Buffart; Marianne Tijssen; Jamila El-Bchiri; Alex Duval; Mark A van de Wiel; Bauke Ylstra; Gerrit A Meijer; Beatriz Carvalho
Journal:  BMC Med Genomics       Date:  2009-06-29       Impact factor: 3.063

8.  Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down.

Authors:  José L Costa; Paul P Eijk; Mark A van de Wiel; Derk ten Berge; Fernando Schmitt; Carmen J Narvaez; JoEllen Welsh; Bauke Ylstra
Journal:  BMC Genomics       Date:  2009-10-28       Impact factor: 3.969

9.  New methods to analyse microarray data that partially lack a reference signal.

Authors:  Neeltje Carpaij; Ad C Fluit; Jodi A Lindsay; Marc Jm Bonten; Rob Jl Willems
Journal:  BMC Genomics       Date:  2009-11-13       Impact factor: 3.969

10.  Intensity-based analysis of dual-color gene expression data as an alternative to ratio-based analysis to enhance reproducibility.

Authors:  Koen Bossers; Bauke Ylstra; Ruud H Brakenhoff; Serge J Smeets; Joost Verhaagen; Mark A van de Wiel
Journal:  BMC Genomics       Date:  2010-02-17       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.